Dyazide

Dyazide is a brand name of hydrochlorothiazide/triamterene, approved by the FDA in the following formulation(s):

DYAZIDE (hydrochlorothiazide; triamterene - capsule; oral)

• 
  Manufacturer: GLAXOSMITHKLINE LLC
  
  Approval date: March 3, 1994
  
  Strength(s): 25MG;37.5MG ^[RLD][AB]

Has a generic version of Dyazide been approved?

Yes. The following products are equivalent to Dyazide:

TRIAMTERENE AND HYDROCHLOROTHIAZIDE (hydrochlorothiazide; triamterene capsule; oral)

• 
  Manufacturer: DURAMED PHARMS BARR
  
  Approval date: June 18, 1999
  
  Strength(s): 25MG;37.5MG ^[AB]


• 
  Manufacturer: LANNETT HOLDINGS INC
  
  Approval date: December 9, 2011
  
  Strength(s): 25MG;37.5MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: June 7, 1996
  
  Strength(s): 25MG;37.5MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: June 5, 1997
  
  Strength(s): 25MG;37.5MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Dyazide. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Dyazide.

See also...

• Dyazide Consumer Information (Drugs.com)
• Dyazide Consumer Information (Wolters Kluwer)
• Dyazide Consumer Information (Cerner Multum)
• Dyazide Advanced Consumer Information (Micromedex)
• Triamterene/Hydrochlorothiazide Consumer Information (Wolters Kluwer)
• Hydrochlorothiazide and triamterene Consumer Information (Cerner Multum)
• Triamterene and hydrochlorothiazide Advanced Consumer Information (Micromedex)